Access cutting-edge smoking cessation treatment through this phase 3 clinical trial at a research site in Skokie. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Skokie location
Preparing your pre-screening questions…
Access smoking cessation specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related smoking cessation treatment provided free
Check if you qualify for this smoking cessation clinical trial in Skokie, IL
No-Cost Study Care
Local to Skokie
Convenient for IL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is a Phase 3, multicenter, randomized, double-blind, placebo- and active-controlled, parallel-group trial to evaluate the efficacy and safety of AXS-05 compared to placebo and bupropion for smoking cessation in adults.
Sponsor: Axsome Therapeutics, Inc.
Yes, this clinical trial (NCT07766655) has an active research site in Skokie, IL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for smoking cessation treatment options in Skokie, IL, this clinical trial (NCT07766655) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Skokie research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced smoking cessation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.